---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-005699"
form_type: "8-K"
ticker: "SFES"
cik: "0000086115"
company_name: "SAFEGUARD SCIENTIFICS INC"
filed_at: "2022-03-09T23:59:59+00:00"
generated_at: "2026-06-27T00:34:20.161903+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Safeguard Scientifics reports $60.8M cash proceeds from 2021 exits; initiates strategic review

## Summary
- Repurchased 4.5M shares in 2021, including 4.3M via Dutch auction at $9.06 per share.
- Received $44.8M from Flashtalking exit, $32.5M gain; $3.5M cash + $15.3M preferred equity from Zipnosis.
- BHG IPO converted preferred to 1.3M common shares; fair value fell to $4.5M by year-end.
- Deployments totaled $2.7M in 2021; funded $2M convertible loan to Prognos Health post-year-end.
- Board initiated evaluation of strategic alternatives to enhance shareholder value.

## SEC filing metadata
- accession: 0001437749-22-005699
- form_type: 8-K
- ticker: SFES
- cik: 0000086115
- company_name: SAFEGUARD SCIENTIFICS INC
- filed_at: 2022-03-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/86115/000143774922005699/0001437749-22-005699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/86115/000143774922005699/sfe20220309_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-005699
- JSON: https://secwatch.observer/filing/0001437749-22-005699.json
- Plain text: https://secwatch.observer/filing/0001437749-22-005699.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.